Size of SOD1 Protein Aggregates in ALS Patients’ Brains Leads to Different Outcomes, Study Shows
Size matters when it comes to SOD1 protein aggregates found in the brains of patients with amyotrophic lateral sclerosis…
Articles by Patricia Inácio, PhD
#AAN2018 — NP001 Fails to Improve Disease Severity, Pulmonary Function in ALS Patients, Phase 2 Trial Shows
Investigational therapy NP001 failed to improve disease severity and pulmonary function in a Phase 2 confirmatory trial for amyotrophic lateral…
#AAN2018 – Diet Rich in Essential Omega-3 Fatty Acid Linked to Lower ALS Risk in Study
A diet that includes foods rich in omega-3 polyunsaturated fatty acids like alpha-linolenic acid — an essential plant-derived fatty acid found in…
#AAN2018 – H.P. Acthar Gel Shows Promise as Therapy to Delay Progression of ALS
H.P. Acthar Gel, an experimental injectable therapy, may help delay progression of amyotrophic lateral sclerosis (ALS), a new analysis reveals.
Tailored Home Exercises May Improve Daily Living of Early-stage ALS Patients, Small Study Suggests
Researchers suggest that patients in the early stage of amyotrophic lateral sclerosis (ALS) may benefit from a personalized program…
NMD Obtains $47 Million in New Financing for Its ALS Therapy Program
NMD Pharma has obtained $47 million in financing from new investors to continue developing treatments for ALS and other neuromuscular…
Kadimastem Plans Phase 1/2a Clinical Trial of Cell Therapy for ALS
The Israeli biotechnology company Kadimastem is planning a Phase 1/2a clinical trial of a cell therapy for ALS after regulators gave…
ALS Patients More Likely to Have Sleep Apnea than General Population, Study Suggests
Patients with amyotrophic lateral sclerosis (ALS) show higher rates of sleep apnea that is often accompanied by nocturnal…
New Browser Allows Sharing of MRI Data on ALS, Other Neurodegenerate Disorders
Difficulty sharing vast amounts of information — the so-called big data — can slow the pace of scientific advancement, experts…
CRISPR-Cas9 Gene Editing Reveals Potential Therapeutic Targets for ALS
Researchers have identified genes that promote amyotrophic lateral sclerosis (ALS), using the gene-editing technology CRISPR-Cas9. The findings represent not only another piece…